Adjust Font Sizing:

New IH Clinical Study

May 13th, 2020

The Sparkle 2002 Study for Idiopathic Hypersomnia

Idiopathic hypersomnia presents daily challenges and frustrations. You may struggle with activities that others take for granted, such as working, driving, and watching television. Even spending time with family and friends can be difficult when you’re constantly fighting to stay awake.

Further development is needed in treating sleep disorders.

What is the purpose of the Sparkle 2002 Study?

This clinical study is testing an investigational drug (TAK-925) to see if it could potentially be a safe and effective way to help increase wakefulness for people with idiopathic hypersomnia.

Is study participation an option for me?

You may qualify if you:

  • Are 18–75 years old
  • Have been diagnosed with idiopathic hypersomnia
  • First experienced the effects of hypersomnia when you were between 10 and 30 years old
  • Meet additional requirements as determined by a screening process

A study doctor and staff can explain to you in greater detail other requirements and eligibility criteria you would have to meet to participate in the study. You will be reimbursed for your time and travel.

To learn more about the Sparkle 2002 Study and to see if you may qualify, visit this website.

# # #
Date Created: May 13th, 2020
Last Updated: July 15th, 2020